Easy to read patient leaflet for palivizumab. Includes indications, proper use, special instructions, precautions, and possible side effects.
For Healthcare Professionals. Recommend on Facebook Tweet Share Compartir. ... Palivizumab is a monoclonal antibody recommended by the American Academy of Pediatrics ...
Learn about the prescription medication Synagis (Palivizumab), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.
Consumer information about the medication PALIVIZUMAB - INJECTION (Synagis), includes side effects, drug interactions, recommended dosages, and storage information.
Official site from MedImmune. Includes prescribing and patient information.
Palivizumab is a man-made antibody to respiratory syncytial (sin-SISH-ul) virus (RSV). RSV can cause serious illness in children. Palivizumab helps keep RSV cells ...
Palivizumab (brand name Synagis which is manufactured by MedImmune) is a monoclonal antibody produced by recombinant DNA technology. It is used in the prevention of ...
Palivizumab vaccine for prevention of respiratory syncytial virus infection in children with cystic fibrosis. ... Show search results within this document
Synagis® (palivizumab) should be administered in a dose of 15 mg/kg intramuscularly using aseptic technique, preferably in the anterolateral aspect of the thigh.
palivizumab [pal″ĭ-viz´u-mab] a monoclonal antibody against respiratory syncytial virus, used as a passive immunizing agent against infection with the virus in ...